Category

Smartkarma Newswire

MGM Resorts International (MGM) Earnings: BetMGM Boosts FY25 Revenue Projection to $2.7 Billion

By | Earnings Alerts
  • BetMGM has raised its fiscal year 2025 guidance.
  • The company expects its net revenue to be at least $2.7 billion.
  • Adjusted EBITDA is reported at $86 million.
  • Total net revenue for a specific period is recorded at $692 million.
  • The $150 million revolving credit facility remains undrawn.
  • No additional capital from parent companies is anticipated.
  • Analyst ratings include 14 buys, 9 holds, and 1 sell.

MGM Resorts International on Smartkarma



Analysts on Smartkarma, like Baptista Research, are optimistic about MGM Resorts International‘s future. In one report titled “MGM Resorts: Japan Integrated Resort Development to Ensure Diversified Growth Beyond North American & Chinese Markets!“, CEO Bill Hornbuckle emphasized operational strength and strategic partnerships during a strong first-quarter 2025 earnings call. The company’s rewards program also saw significant growth, surpassing 50 million members, a 50% increase since 2020.

Another report by Baptista Research, “MGM Resorts International: Leveraging Partnerships & Loyalty Programs To Redefine the Industry!”, highlighted MGM’s record-breaking earnings in the fourth quarter and full year of 2024. The company attributes its success to robust strategic decisions, financial stability, and improvements in customer service, as reflected in record high Net Promoter Scores for Gold Plus customers. These positive sentiments point towards a promising outlook for MGM Resorts International.



A look at MGM Resorts International Smart Scores

FactorScoreMagnitude
Value3
Dividend1
Growth3
Resilience3
Momentum5
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, MGM Resorts International shows a promising long-term outlook. With a strong momentum score of 5, indicating positive market momentum, the company is likely to continue its upward trend. Additionally, MGM Resorts scores well in terms of value, growth, and resilience, all coming in at a solid 3. These scores suggest that the company is positioned well for sustainable growth and has a solid financial foundation.

As a company that operates gaming, hospitality, and entertainment resorts across various locations in the United States and Macau, MGM Resorts International appears to have a diverse portfolio and a strong presence in key markets. With its strength in momentum and resilience, coupled with a focus on growth, MGM Resorts seems well-equipped to navigate challenges and capitalize on opportunities in the industry.

### MGM Resorts International operates gaming, hospitality and entertainment resorts. The Company owns properties in Nevada, Mississippi and Michigan in the United States; and owns interests in properties in Nevada and Illinois in the United States, and Macau. MGM Resorts also offers hospitality management services for casino and non-casino properties around the world. ###


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Games Workshop Group PLC (GAW) Earnings: FY Pretax Profit Hits GBP262.8M with Strong Core Revenue

By | Earnings Alerts
  • The pretax profit for Games Workshop was GBP262.8 million.
  • The company reported core revenue of GBP565.0 million.
  • Analyst recommendations include three buys and no holds or sells.

A look at Games Workshop Group PLC Smart Scores

FactorScoreMagnitude
Value2
Dividend3
Growth4
Resilience5
Momentum4
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Games Workshop Group PLC, known for its tabletop war-game systems and miniature products, has a promising long-term outlook supported by its Smartkarma Smart Scores. With a strong score of 5 in Resilience and a solid score of 4 in both Growth and Momentum, the company shows robustness and potential for future expansion. Additionally, its Dividend score of 3 signifies a stable payout to investors, while its Value score of 2 indicates a reasonable valuation in the market. Overall, Games Workshop Group PLC seems well-positioned for sustained growth and resilience in the industry.

Games Workshop Group PLC, a manufacturer and retailer of tabletop war-game systems and miniatures, maintains a diverse global presence with operations in the UK, North America, Continental Europe, and Australia. The company’s Smartkarma Smart Scores illustrate a favorable outlook, with high scores in Resilience and Growth, indicating its ability to weather market challenges and capitalize on expansion opportunities. With a balanced approach to dividends and relative valuation, Games Workshop Group PLC showcases a compelling investment proposition for the long term.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Croda International (CRDA) Earnings: 1H Adjusted Operating Profit Falls Short of Estimates

By | Earnings Alerts
  • Adjusted operating profit was GBP146.9 million, slightly below the estimated GBP149.4 million.
  • Consumer Care adjusted profit came in at GBP85.7 million, missing the estimate of GBP88.1 million.
  • Life Sciences adjusted profit exceeded projections, reaching GBP56.1 million against an estimate of GBP54.5 million.
  • Industrial Specialties adjusted profit was GBP5.1 million, less than the expected GBP6.46 million.
  • Total sales were reported at GBP855.8 million, marginally surpassing the estimate of GBP855.3 million.
  • Consumer Care sales reached GBP491.8 million, slightly above the forecasted GBP490.6 million.
  • Life Sciences sales amounted to GBP261.0 million, just below the expected GBP264.2 million.
  • Industrial Specialties sales were GBP103.0 million, near the estimate of GBP103.1 million.
  • Adjusted pretax profit matched closer to expectations at GBP138.0 million, with an estimate of GBP138.2 million.
  • Pretax profit was significantly lower at GBP85.5 million compared to the anticipated GBP114.9 million.
  • Market experts issued 7 “buy” ratings, 6 “hold” ratings, and 2 “sell” ratings.

A look at Croda International Smart Scores

FactorScoreMagnitude
Value3
Dividend4
Growth2
Resilience3
Momentum2
OVERALL SMART SCORE2.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts are divided on the long-term outlook for Croda International, with a mixed bag of Smart Scores indicating various aspects of the company’s performance. With a solid score in Dividend at 4, investors can expect a decent return in the form of dividends. However, the Growth and Momentum scores are comparatively lower at 2, suggesting a slower growth trajectory and weaker market momentum in the near future. The Value and Resilience scores stand at 3, pointing towards moderate indicators in these areas.

Croda International plc, known for its diverse range of chemicals and chemical products, caters to a wide array of industries ranging from personal care to automotive. While the company has a good track record in paying dividends, the lower scores in Growth and Momentum may indicate challenges in accelerating its growth and market performance. Investors should keep a close watch on how Croda navigates these factors to improve its overall outlook in the long term.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Stellantis NV (STLA) Earnings Report Shows Significant Decline in Net Revenue and Operating Income

By | Earnings Alerts
  • Stellantis expects a significant net tariff impact of approximately €1.2 billion in the second half of 2025.
  • The company’s adjusted operating income dropped dramatically by 94% year-on-year to €540 million compared to an estimate of €1.33 billion.
  • Adjusted operating margin fell to 0.7%, down from 10% the previous year, missing the estimate of 1.97%.
  • Experienced a sharp increase in negative industrial free cash flow, reporting €3.01 billion compared to a negative €392 million year-on-year, against an estimated negative €2 billion.
  • Stellantis reported a net loss of €2.26 billion, compared to a profit of €5.65 billion the previous year, and the estimated loss of €855.3 million.
  • Net revenue decreased by 13% to €74.26 billion, below the estimate of €74.96 billion.
  • Regional revenue performance varied:
    • North America: €28.20 billion, a 26% decrease year-on-year, below the estimate of €29.27 billion.
    • Enlarged Europe: €29.24 billion, a 2.4% decline year-on-year, slightly above the estimate of €29.02 billion.
    • South America: €7.77 billion, a 5.5% increase year-on-year, close to the estimate of €7.78 billion.
    • Middle East & Africa: €4.94 billion, a 1.2% decline year-on-year, above the estimate of €4.7 billion.
    • China, India & Asia Pacific: €923 million, a 14% decrease year-on-year, below the estimate of €1.05 billion.
    • Maserati: €369 million, a 42% decrease year-on-year, below the estimate of €398.6 million.
  • Vehicle sales across regions also showed mixed results:
    • North America: 647,000 units, down 23% year-on-year, below the estimate of 684,781 units.
    • Enlarged Europe: 1.29 million units, a 7.1% decrease year-on-year, slightly above the estimate of 1.28 million units.
    • South America: 471,000 units, a 20% increase year-on-year, above the estimate of 446,174 units.
    • Middle East & Africa: 225,000 units, a 5.1% increase year-on-year, above the estimate of 209,950 units.
    • China, India & Asia Pacific: 28,000 units, a 13% decrease year-on-year, below the estimate of 29,931 units.
    • Maserati: 4,200 units, a 35% decrease year-on-year, slightly below the estimate of 4,231 units.
  • Stellantis anticipates increasing net revenues in the second half of 2025 compared to the first half.
  • Expects the adjusted operating income margin to be in the low-single digits in the second half.
  • Aims for an improvement in industrial free cash flow in the second half compared to the first half.
  • Assumptions for future performance are based on current tariff and trade rules as of July 29, 2025.

Stellantis NV on Smartkarma

According to analyst coverage on Smartkarma by Baptista Research, Stellantis NV is experiencing a mixed financial performance in 2024 amidst significant challenges and strategic shifts. The company is facing declining revenues, reduced vehicle shipments, and pressures on operating margins. Despite these obstacles, Stellantis is aiming to overcome them by prioritizing growth, execution, and profitability as key strategic pillars moving forward into 2025.

On the other hand, Baptista Research also highlights that Stellantis NV is grappling with a tough operating environment, marked by tariffs, layoffs, and factory pauses. The reimposition of 25% tariffs on auto imports has led to various financial and operational consequences for Stellantis, including production halts at key plants, layoffs of hundreds of U.S. workers, and credit rating downgrades. Despite these challenges, there is optimism about a potential turnaround taking shape within the company, signaling resilience and adaptability in the face of adversity.


A look at Stellantis NV Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth2
Resilience3
Momentum2
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Stellantis NV, a company that produces automobiles and commercial vehicles, is poised with a promising long-term outlook according to Smartkarma’s Smart Scores. With a top score in both Value and Dividend factors, the company showcases financial strength and commitment to providing returns to its investors. Despite slightly lower scores in Growth and Momentum, Stellantis still demonstrates resilience in the face of challenges, positioning itself as a stable investment option for the future. Serving customers globally, Stellantis NV‘s diversified business operations contribute to its overall positive outlook.

Smartkarma’s Smart Scores for Stellantis NV emphasize the company’s strong value proposition and attractive dividend offerings. While growth and momentum factors may not be as high, the company’s resilience and diversified business model are key strengths that contribute to its overall positive outlook. Stellantis’ global presence and broad range of offerings in the automobile industry, alongside its additional ventures into metallurgical products and production systems, further bolster its position for long-term success in the market.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Unite Group (UTG) Earnings: Strong H1 Performance and Optimistic EPS Guidance for 2025

By | Earnings Alerts
  • Unite Group reported an EPRA EPS of 28.0p for the first half of the year.
  • The rental income for the period was GBP 236.6 million.
  • EPRA net tangible assets per share were recorded at 986p.
  • The company is maintaining its full-year 2025 adjusted EPS guidance at 47.5-48.25p.
  • For the 2025/26 period, Unite Group aims for rental growth of 4-5% and a minimum occupancy rate of 97%.
  • The outlook for 2025/26 remains promising due to a rise in student numbers, driven by an increase in the UK’s 18-year-old population and favorable international student recruitment trends.
  • Analyst recommendations include 7 buys, 3 holds, and 1 sell.

A look at Unite Group Smart Scores

FactorScoreMagnitude
Value5
Dividend4
Growth3
Resilience4
Momentum3
OVERALL SMART SCORE3.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

With a strong overall outlook indicated by the Smartkarma Smart Scores, The UNITE Group PLC appears to be positioned well for the long term. The company scores high in Value, highlighting its attractiveness from an investment perspective. Additionally, its above-average scores in Dividend and Resilience indicate stability and consistent returns for investors. These factors suggest a promising future for Unite Group in the property investment sector.

While the company scores slightly lower in Growth and Momentum, its core strengths in Value, Dividend, and Resilience provide a solid foundation for sustained performance. As a property investment company specializing in student accommodation in the UK, Unite Group‘s established links with academic institutions further bolster its position in the market. With a robust business model and strategic partnerships, the company is well-equipped to navigate challenges and capitalize on opportunities in the evolving real estate landscape.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Inchcape PLC (INCH) Earnings Fall Short: 1H Adjusted Operating Profit Below Estimates

By | Earnings Alerts
  • Inchcape’s adjusted operating profit for the first half of the year was Β£247 million, which missed the estimated Β£262 million.
  • The adjusted pretax profit was Β£200 million.
  • Inchcape generated free cash flow amounting to Β£72 million.
  • The company’s revenue totaled Β£4.32 billion for the first half of the year.
  • An interim dividend of 9.5p per share has been declared.
  • Inchcape aims for an earnings per share growth rate of over 10% compounded annually over the medium term.
  • The company attributes this target to its capital allocation policy, market leadership, diversification, cost discipline, inventory management, and technology platform.
  • Among analysts, there are 5 buy ratings, 3 hold ratings, and no sell ratings for Inchcape.

A look at Inchcape PLC Smart Scores

FactorScoreMagnitude
Value3
Dividend4
Growth4
Resilience3
Momentum3
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Inchcape PLC, a global automotive distributor and retailer, holds promising prospects for long-term growth as per Smartkarma Smart Scores. With a solid score in Dividend and Growth factors, the company is positioned well to deliver stable returns and exhibit strong potential for expansion. Additionally, its Resilience score underscores its ability to withstand market challenges and maintain a steady performance over time. Inchcape’s strategic focus on premium and luxury brands in key markets enhances its competitive advantage and growth opportunities in the automotive sector.

Moreover, while the company’s Value and Momentum scores are not the highest, its overall consistent performance across various factors indicates a balanced outlook for the future. Inchcape PLC‘s strong presence in Asia Pacific and emerging markets further solidifies its position as a key player in the industry, with significant profit contributions from these regions. This diversified geographic exposure aligns well with the company’s growth strategy and underscores its potential for long-term success in the global automotive market.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Barclays PLC (BARC) Earnings: Q2 Investment Bank Revenue Surges Past Estimates

By | Earnings Alerts
  • Barclays Investment Bank’s 2Q revenue: GBP3.31 billion, surpassing the estimate of GBP3.07 billion.
  • FICC revenue: GBP1.45 billion, beating the expected GBP1.27 billion.
  • Equities revenue: GBP870 million, exceeding the estimate of GBP754.6 million.
  • Investment banking fees fell short at GBP568 million, compared to the estimate of GBP601.7 million.
  • Corporate lending registered an expense of GBP4 million, contrary to the estimated income of GBP58.8 million.
  • Transaction banking income slightly surpassed estimates at GBP423 million versus GBP408.3 million.
  • Total income reached GBP7.19 billion, ahead of the GBP6.98 billion estimate.
  • UK Personal Banking revenue was slightly below expectations at GBP1.38 billion versus GBP1.4 billion.
  • UK Barclaycard Consumer revenue came in lower at GBP218 million, compared to the anticipated GBP240.9 million.
  • UK Business Banking revenue slightly exceeded estimates at GBP520 million against GBP517.1 million.
  • Barclays UK overall revenue: GBP2.12 billion, missing the target of GBP2.16 billion.
  • UK Corporate Bank revenue exceeded expectations at GBP519 million compared to the forecasted GBP485.8 million.
  • Private Bank and Wealth Management revenue slightly below estimate at GBP348 million versus GBP351.1 million.
  • US Consumer Bank revenue came in lower at GBP823 million, against a forecast of GBP851.2 million.
  • Net interest income achieved GBP3.51 billion, higher than the estimated GBP3.47 billion.
  • Pretax profit reached GBP2.48 billion, exceeding the estimate of GBP2.26 billion.
  • Attributable profit was GBP1.66 billion, higher than the forecasted GBP1.46 billion.
  • Return on tangible equity was recorded at +12.3%, above the expectation of +11.3%.
  • Cost to Income Ratio aligned with expectations at 59%.
  • Common equity Tier 1 ratio maintained at 14%, as estimated.
  • Risk-weighted assets slightly over the estimate at GBP353.0 billion compared to GBP352.72 billion.
  • Total operating expenses came in at GBP4.23 billion, above the estimated GBP4.16 billion.
  • Provision for loan losses was significantly lower than expected at GBP469.0 million, against an estimate of GBP560.3 million.
  • Analyst ratings: 15 buys, 5 holds, 1 sell.

A look at Barclays PLC Smart Scores

FactorScoreMagnitude
Value4
Dividend3
Growth5
Resilience5
Momentum5
OVERALL SMART SCORE4.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Barclays PLC, a global financial services provider, seems to have a promising long-term outlook based on the Smartkarma Smart Scores analysis. The company has received strong ratings across various key factors. With top scores in Growth, Resilience, and Momentum categories, Barclays appears to be well-positioned in terms of its business expansion, ability to withstand challenges, and overall market momentum.

Notably, Barclays also holds a solid Value score, further indicating the company’s attractive valuation metrics. While the Dividend score is slightly lower, Barclays’ robust performance in growth, resilience, and momentum suggests a positive trajectory for the company’s future. Overall, Barclays PLC may offer investors a compelling opportunity as it navigates the dynamic landscape of financial services with a diversified service portfolio.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

AstraZeneca PLC (AZN) Earnings: 2Q Core EPS Hits Estimates Amid Robust Product Sales

By | Earnings Alerts
  • AstraZeneca’s Core Earnings Per Share (EPS) for the second quarter of 2025 was $2.17, matching analysts’ estimates.
  • The company’s core operating profit reached $4.58 billion, slightly surpassing the estimated $4.5 billion.
  • Core gross profit totaled $11.91 billion, exceeding the anticipated $11.76 billion, while the core gross margin was recorded at 82%, just shy of the 82.3% expectation.
  • Collaboration revenue fell significantly short of expectations, bringing in $8 million compared to an estimated $45.8 million.
  • Alliance revenue outperformed estimates, generating $654 million against the forecasted $640.9 million.
  • Product sales were strong, totaling $13.80 billion compared to the $13.44 billion estimate.
  • Key pharmaceutical products showed varying results: Tagrisso earned $1.81 billion, Lynparza $838 million, Calquence $872 million, and Imfinzi $1.46 billion, all meeting or exceeding expectations.
  • Fasenra and Farxiga revenues were particularly robust, with respective earnings of $502 million and $2.15 billion, both surpassing estimates.
  • Nexium and Crestor revenues reached $201 million and $320 million, with Crestor surpassing the expected $299.2 million.
  • Brilinta’s revenue fell short of projections, achieving $215 million versus an estimated $252.1 million.
  • Symbicort, Ultomiris, and Soliris revenues all exceeded their forecasts, contributing positively to overall sales.
  • Strensiq and Saphnelo revenues were above estimates, while Breztri revenue underperformed, bringing in $283 million compared to the expected $301.1 million.
  • AstraZeneca anticipates that full-year 2025 Total Revenue and Core EPS growth will be broadly similar to growth at constant exchange rates (CER), given stable foreign exchange rates.
  • The company’s financial guidance for the full year 2025 remains unchanged, based on the average foreign exchange rates through 2024.
  • Market sentiment is largely positive with 26 buy ratings, 5 hold ratings, and no sell ratings as reported by analysts.

A look at AstraZeneca PLC Smart Scores

FactorScoreMagnitude
Value2
Dividend3
Growth5
Resilience3
Momentum3
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

AstraZeneca PLC, as indicated by its Smart Scores, shows a promising long-term outlook in various key factors. With a strong emphasis on growth, the company scores a high 5 in this aspect, indicating positive potential for expansion and development. Additionally, AstraZeneca also demonstrates steady momentum and resilience with scores of 3 in both categories, showcasing its ability to adapt to changing market conditions and maintain a consistent performance. While value and dividend scores are slightly lower, at 2 and 3 respectively, the company’s focus on innovation and growth positions it well for future success.

Operating as a holding company, AstraZeneca PLC is engaged in researching, manufacturing, and selling pharmaceutical and medical products through its subsidiaries. The company’s primary focus lies in eight therapeutic areas, including gastrointestinal, oncology, cardiovascular, respiratory, central nervous system, pain control, anaesthesia, and infection. With a strong emphasis on growth and a resilient operational framework, AstraZeneca is poised to navigate challenges and capitalize on opportunities in the pharmaceutical industry moving forward.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Convatec (CTEC) Earnings: 1H Revenue Meets Estimates, Strong Performance and Positive Outlook for FY25

By | Earnings Alerts
  • Convatec reported first-half revenue of $1.18 billion, exactly meeting estimates.
  • Advanced Wound Care revenue was slightly above expectations at $367 million versus an estimate of $366.3 million.
  • Adjusted gross profit came in at $711.1 million, slightly below the projected $720.6 million.
  • Adjusted EBIT was $251.8 million, just under the estimate of $253.1 million.
  • Adjusted net income slightly exceeded expectations at $164.6 million, against an estimate of $164 million.
  • Adjusted EPS was 8.0 cents per share, surpassing the estimate of 7.9 cents.
  • Reported EBIT was $179.2 million, behind the anticipated $188.5 million.
  • The interim dividend per share was 1.877 cents, falling short of the estimated 1.967 cents.
  • Convatec is confident in meeting the financial guidance set for the full fiscal year 2025.
  • The adjusted book tax rate is expected to be around 24%, similar to FY24, with a significantly lower cash tax rate.
  • Analyst recommendations for Convatec include 14 buy ratings, 4 hold ratings, and no sell ratings.

A look at Convatec Smart Scores

FactorScoreMagnitude
Value2
Dividend3
Growth5
Resilience3
Momentum4
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Convatec, a company specializing in the manufacturing of medical and surgical equipment, holds a promising long-term outlook based on Smartkarma’s Smart Scores. With a strong score of 5 in Growth, Convatec is positioned well for future expansion and development. This indicates that the company has good potential for increasing its market presence and enhancing its product offerings in the medical equipment sector.

Additionally, Convatec‘s Momentum score of 4 signifies positive market momentum, suggesting that the company is experiencing favorable trends in its stock performance. While the Value score of 2 reflects some room for improvement in terms of the company’s valuation, the scores for Dividend and Resilience at 3 each show stability and a moderate level of dividend payout. Overall, based on the Smartkarma Smart Scores, Convatec appears to have a solid foundation for sustained growth and market presence in the long run.

### ConvaTec Group PLC manufactures medical and surgical equipment. The Company offers urine meters, dressings, negative pressure wound systems, adhesive removers, and infusion devices. ConvaTec Group markets its products worldwide. ###


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Allfunds Group (ALLFG) Earnings: 1H Adjusted EBITDA Rises by 3.6% Amid Strong Revenue Growth

By | Earnings Alerts
  • Allfunds reported an adjusted EBITDA of €205.9 million for the first half of 2025, marking a 3.6% increase compared to the previous year.
  • The adjusted EBITDA margin slightly decreased to 65% from 66.7% year-over-year.
  • Assets under administration experienced significant growth, reaching €1.60 trillion, which is a 17% increase compared to the same period last year.
  • Revenue increased by 6.2% year-over-year, totaling €316.8 million.
  • Investor sentiments are generally positive with 14 buy recommendations, 3 hold recommendations, and no sell recommendations.

A look at Allfunds Group Smart Scores

FactorScoreMagnitude
Value3
Dividend2
Growth2
Resilience3
Momentum5
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Looking ahead, Allfunds Group, a wealthtech company operating globally, shows a promising long-term outlook based on the Smartkarma Smart Scores. With a strong momentum score of 5, the company is exhibiting robust performance trends, indicating potential for continued growth and market success. Additionally, Allfunds Group maintains a decent value score of 3, highlighting its attractiveness in terms of investment value. While the dividend and growth scores are moderate at 2, the company’s resilience score of 3 suggests its ability to withstand economic challenges. Overall, Allfunds Group‘s positive momentum score coupled with its resilience and value scores indicate a favorable outlook for the company in the long run.

Allfunds Group plc’s operations as a wealthtech company encompass a range of services including data and analytics, portfolio tools, research, and regulatory support, catering to clients worldwide. With a comprehensive suite of offerings tailored to meet the needs of its diverse customer base, the company is well-positioned to capitalize on its strong momentum score and solid resilience in the face of market fluctuations. While the dividend and growth scores are average, Allfunds Group‘s overall outlook appears optimistic, supported by its strategic focus on delivering innovative solutions in the wealth management industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars